_________
C004
אקס טי אל ביופרמסוטיקלס בע"מ
2
Public
X T L BIOPHARMACEUTICALS LTD
4313
Corporation no:
520039470
Stock Exchange/Market:
אקס טי אל
1996
352
Hasapir
3
,
Nes Ziona
76100
,
,
Tel:
08-9304444
,
Fax:
08-9304445
E.mail address:
rcohen@xtlbio.com
Date of transmission:
22/08/2007
Time of broadcast:
10:08
09:58:54
Reference:
2007-02-366820
Israel Securities Authority
Tel Aviv Stock Exchange
www.isa.gov.il
www.tase.co.il
Immediate report on other matter
Don't use this form if there is more adequate one
Company's CEO Ron Bentsur, purchaded yesterday a total of 15,279 American Depositary Receipts (ADRs) at an average price of $1.30 per ADR. This brings his direct holdings up to 20,101 ADRs. Company's Director of Finance Bill Kessler, purchaded yesterday a total of 5,000 ADRs at an average price of $1.29 per ADR. This brings his direct holdings up to 5,000 ADRs. Each ADR equals to 10 ordinary shares of the Company.
Attached file
_________
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure:
28/06/2007
Name of the Signatory:
:
Kantor Ronen
,
,
Position of Signatory in the reporting corporation:
Legal Consultant & Corporate Secretary
Abba Hillel Silver
Telephone:
03-6133371
,
Facsimile:
03-6133372
,
E-mail:
rkantor@kantor-law.com